In the patients included in the INGRAPH study, plasma CRP was slightly increased in PKU patients versus controls, which could be indicative of increased cardiovascular risk, as Ross et al. suggested in 1999,20 but the difference observed did not reach statistical significance. The gene discussed is CRP; the disease is phenylketonuria.